Cancer vaccines

Jan 1, 1996·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·G D MacLeanB M Longenecker

Allogeneic murine melanoma cell vaccine: a model for the development of human allogeneic cancer vaccine

Aug 1, 1996·Melanoma Research·B C KnightA G Dalgleish

Is cancer dangerous to the immune system?

Oct 1, 1996·Seminars in Immunology·E J Fuchs, P Matzinger

Tumor antigens recognized by T cells

Jun 1, 1997·Immunology Today·T BoonB Van den Eynde

Serological analysis of human tumor antigens: molecular definition and implications

Aug 1, 1997·Molecular Medicine Today·O TüreciM Pfreundschuh

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

Mar 21, 1998·Nature Medicine·S A RosenbergD E White

Aspirin and gastrointestinal cancer

Jan 1, 1997·Advances in Experimental Medicine and Biology·M J Thun

Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine

Sep 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E C HsuehD L Morton

Immunotherapy of advanced prostate cancer: a phase I/II trial using Mycobacterium vaccae (SRL172)

Nov 7, 1998·British Journal of Urology·D HroudaA G Dalgleish

Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): correlation with survival

Nov 27, 1998·Annals of Surgical Oncology·E C HsuehD L Morton

Comparison of four strategies for tumour vaccination in the B16-F10 melanoma model

Feb 4, 1999·Gene Therapy·B E SouberbielleA G Dalgleish

The TRAIL to selective tumor death

Feb 4, 1999·Nature Medicine·L E French, J Tschopp

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

Feb 9, 1999·Lancet·J B VermorkenH M Pinedo

BCG immunotherapy of bladder cancer: 20 years on

May 21, 1999·Lancet·A B AlexandroffK James

Intravesical bacille Calmette-Guérin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up

Aug 12, 1999·Urology·R HurleA Lembo

Development of dendritic cells and their use in tumor therapy

Aug 13, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·P Björck

Role of dendritic cells in the induction and maintenance of autoimmune diseases

Aug 18, 1999·Immunological Reviews·B LudewigH Hengartner

Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine

Sep 1, 1999·Gene Therapy·J KayagaA G Dalgleish

Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes

Sep 2, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A MaraveyasA G Dalgleish

Tumour escape from the immune response: the last hurdle for successful immunotherapy of cancer?

Sep 29, 1999·Cancer Immunology, Immunotherapy : CII·G Pawelec

How tumors escape immune destruction and what we can do about it

Sep 29, 1999·Cancer Immunology, Immunotherapy : CII·E Gilboa

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

Sep 30, 1999·Nature Medicine·M BendandiL W Kwak

Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients

Nov 7, 1999·Cancer Immunology, Immunotherapy : CII·S GotoS Takeuchi

Human tumor antigens for cancer vaccine development

Nov 24, 1999·Immunological Reviews·R F Wang, S A Rosenberg

The relevance of non-linear mathematics (chaos theory) to the treatment of cancer, the role of the immune response and the potential for vaccines

Jan 5, 2000·QJM : Monthly Journal of the Association of Physicians·A Dalgleish

Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines

Mar 4, 2000·Biochimica Et Biophysica Acta·T H Scott-TaylorA G Dalgleish

Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection

Mar 29, 2000·British Journal of Cancer·A G HeriotA G Dalgleish

Prospects for vaccination in prostate cancer

Aug 5, 2000·Drugs & Aging·M J PerryA G Dalgleish

❮ Previous

Next ❯

Citations

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model

Jun 26, 2004·Breast Cancer Research : BCR·Yesim EralpLawrence B Lachman

The immune-enhancing effect of the herbal combination Bouum-Myunyuk-Dan

Jan 8, 2004·Biological & Pharmaceutical Bulletin·Hyun-Ja JeongHyung-Min Kim

Immune-enhancing effect of the Korean natural medicine WooKiEum

Oct 7, 2004·Biological & Pharmaceutical Bulletin·Hye-Young ShinHyung-Min Kim

Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment

Jun 28, 2008·Scandinavian Journal of Gastroenterology·Nanna Møller SørensenNils Brünner

Active and passive immunization for cancer

Nov 27, 2014·Human Vaccines & Immunotherapeutics·David Baxter

Cancer gene therapy: developments to 2000

Nov 28, 2000·Expert Opinion on Investigational Drugs·A R BatemanR G Vile

Therapeutic cancer vaccines on trial

Jun 29, 2002·Nature Biotechnology·Janice M Reichert, Cherie Paquette

The promise of cancer vaccines

May 4, 2004·Nature Reviews. Cancer·Eli Gilboa

The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma model

Sep 15, 2005·Cancer Immunology, Immunotherapy : CII·Marie-Christine LabartheStephen John Ward

Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity

May 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Keith DredgeAngus G Dalgleish

❮ Previous

Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer vaccines

Abstract

References

BCG therapy in acute non lymphoid leukaemias

Prospective comparison of intralesional and multipuncture BCG in recurrent intradermal melanoma

Immunotherapy of melanoma

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine

Coley toxins--the first century

Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action

The significance of conversion of skin reactivity to efficacy of bacillus Calmette-Guérin (BCG) vaccinations given immediately after radical surgery in stage II melanoma patients.

Bacillus calmette-guerin (BCG) adjuvant therapy in stage D prostate cancer

Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia

Heat shock protein-peptide complexes in cancer immunotherapy

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

Pooled analysis of the efficacy of bacille Calmette-Guerin (BCG) immunotherapy in malignant melanoma

The case for therapeutic vaccines

Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine

Allogeneic murine melanoma cell vaccine: a model for the development of human allogeneic cancer vaccine

Is cancer dangerous to the immune system?

Tumor antigens recognized by T cells

Serological analysis of human tumor antigens: molecular definition and implications

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

Aspirin and gastrointestinal cancer

Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine

Immunotherapy of advanced prostate cancer: a phase I/II trial using Mycobacterium vaccae (SRL172)

Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): correlation with survival

Comparison of four strategies for tumour vaccination in the B16-F10 melanoma model

The TRAIL to selective tumor death

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

BCG immunotherapy of bladder cancer: 20 years on

Intravesical bacille Calmette-Guérin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up

Development of dendritic cells and their use in tumor therapy

Role of dendritic cells in the induction and maintenance of autoimmune diseases

Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine

Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes

Tumour escape from the immune response: the last hurdle for successful immunotherapy of cancer?

How tumors escape immune destruction and what we can do about it

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients

Human tumor antigens for cancer vaccine development

The relevance of non-linear mathematics (chaos theory) to the treatment of cancer, the role of the immune response and the potential for vaccines

Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines

Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection

Prospects for vaccination in prostate cancer

Citations

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model

The immune-enhancing effect of the herbal combination Bouum-Myunyuk-Dan

Immune-enhancing effect of the Korean natural medicine WooKiEum

Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment

Active and passive immunization for cancer

Cancer gene therapy: developments to 2000

Therapeutic cancer vaccines on trial

The promise of cancer vaccines

The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma model

Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity

Related Concepts

Related Feeds

Cancer Vaccines

CREs: Gene & Cell Therapy

Related Papers

Cancer vaccines

Cancer vaccines

Cancer vaccines

Cancer vaccines

Cancer vaccines